1,758
Views
0
CrossRef citations to date
0
Altmetric
Psychiatry

Development and initial testing of mindful journey: a digital mindfulness-based intervention for promoting recovery from Substance use disorder

, , , , , , , , , , , , , , , , & show all
Article: 2315228 | Received 19 Oct 2023, Accepted 30 Jan 2024, Published online: 21 Feb 2024

References

  • Rehm J, Shield KD. Global burden of disease and the impact of mental and addictive disorders. Curr Psychiatry Rep. 2019;21(2):1. doi:10.1007/s11920-019-0997-0.
  • McKay JR. Continuing care research: what we have learned and where we are going. J Subst Abuse Treat. 2009;36(2):131–22. doi:10.1016/j.jsat.2008.10.004.
  • McLellan AT, Lewis DC, O’Brien CP, et al. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. J Am Med Assoc. 2000;284(13):1689–1695. doi:10.1001/jama.284.13.1689.
  • McLellan AT, McKay JR, Forman R, et al. The evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring. Addiction. 2005;100(4):447–458. doi:10.1111/j.1360-0443.2005.01012.x.
  • Moos RH, Moos BS. Rates and predictors of relapse after natural and treated remission from alcohol use disorders. Addiction. 2006;101(2):212–222. doi:10.1111/j.1360-0443.2006.01310.x.
  • UDo H, Services H. Facing addiction in america: the surgeon general’s report on alcohol, drugs, and health. Washington, DC: HHS; 2016. p. 3–1.
  • Koob GF. The neurocircuitry of addiction: implications for treatment. Clinical Neuroscience Research. 2005;5(2-4):89–101. doi:10.1016/j.cnr.2005.08.005.
  • Witkiewitz K, Montes KS, Schwebel FJ, et al. What is recovery? Alcohol Res. 2020;40(3):01. doi:10.35946/arcr.v40.3.01.
  • McHugh RK, Kneeland ET. Affective vulnerability in substance use disorders. Curr Opin Psychol. 2019;30:54–58. doi:10.1016/j.copsyc.2019.01.011.
  • Cheetham A, Allen NB, Yücel M, et al. The role of affective dysregulation in drug addiction. Clin Psychol Rev. 2010;30(6):621–634. doi:10.1016/j.cpr.2010.04.005.
  • Bresin K, Mekawi Y, Verona E. The effect of laboratory manipulations of negative affect on alcohol craving and use: a meta-analysis. Psychol Addict Behav. 2018;32(6):617–627. doi:10.1037/adb0000383.
  • Cavicchioli M, Movalli M, Maffei C. The clinical efficacy of mindfulness-based treatments for alcohol and drugs use disorders: a meta-analytic review of randomized and nonrandomized controlled trials. Eur Addict Res. 2018;24(3):137–162. doi:10.1159/000490762.
  • Stellern J, Xiao KB, Grennell E, et al. Emotion regulation in substance use disorders: a systematic review and meta-analysis. Addiction. 2023;118(1):30–47. doi:10.1111/add.16001.
  • Weiss NH, Kiefer R, Goncharenko S, et al. Emotion regulation and substance use: a meta-analysis. Drug Alcohol Depend. 2022;230:109131. doi:10.1016/j.drugalcdep.2021.109131.
  • Xiao KB, Stellern J, Grennell E, et al. P4. Difficulties in emotion regulation in substance use disorders: a Meta-Analysis. Biolog Psychiatry. 2022;91(9):S89. doi:10.1016/j.biopsych.2022.02.239.
  • Vafaie N, Kober H. Association of drug cues and craving with drug use and relapse: a systematic review and meta-analysis. JAMA Psychiatry. 2022;79(7):641–650.
  • Serre F, Fatseas M, Swendsen J, et al. Ecological momentary assessment in the investigation of craving and substance use in daily life: a systematic review. Drug Alcohol Depend. 2015;148:1–20. doi:10.1016/j.drugalcdep.2014.12.024.
  • Sayette MA. The role of craving in substance use disorders: theoretical and methodological issues. Annu Rev Clin Psychol. 2016;12(1):407–433. doi:10.1146/annurev-clinpsy-021815-093351.
  • Cavicchioli M, Vassena G, Movalli M, et al. Is craving a risk factor for substance use among treatment-seeking individuals with alcohol and other drugs use disorders? A meta-analytic review. Drug Alcohol Depend. 2020;212:108002. doi:10.1016/j.drugalcdep.2020.108002.
  • Kiluk BD, Yip SW, DeVito EE, et al. Anhedonia as a key clinical feature in the maintenance and treatment of opioid use disorder. Clin Psychol Sci. 2019;7(6):1190–1206. doi:10.1177/2167702619855659.
  • Garfield JB, Lubman DI, Yücel M. Anhedonia in substance use disorders: a systematic review of its nature, course and clinical correlates. Aust N Z J Psychiatry. 2014;48(1):36–51. doi:10.1177/0004867413508455.
  • Bishop SR, Lau M, Shapiro S, et al. Mindfulness: a proposed operational definition. Clin Psychol Sci Pract. 2004;11(3):230–241. doi:10.1093/clipsy.bph077.
  • Bowen S, Chawla N, Grow J, et al. Mindfulness-based relapse prevention for. In: Addictive behaviors. Guilford Publications; 2021.
  • Garland EL, Baker AK, Riquino MR, et al. Mindfulness-oriented recovery enhancement: a review of its theoretical underpinnings, clinical application, and biobehavioral mechanisms. In: Handbook of mindfulness-based programmes. New York (NY): Routledge; 2019. p. 327–340.
  • Hayes SC, Luoma JB, Bond FW, et al. Acceptance and commitment therapy: model, processes and outcomes. Behav Res Ther. 2006;44(1):1–25. doi:10.1016/j.brat.2005.06.006.
  • Li W, Howard MO, Garland EL, et al. Mindfulness treatment for substance misuse: a systematic review and meta-analysis. J Subst Abuse Treat. 2017;75:62–96. doi:10.1016/j.jsat.2017.01.008.
  • Goldberg SB, Tucker RP, Greene PA, et al. Mindfulness-based interventions for psychiatric disorders: a systematic review and meta-analysis. Clin Psychol Rev. 2018;59:52–60. doi:10.1016/j.cpr.2017.10.011.
  • Bowen S, Witkiewitz K, Clifasefi SL, et al. Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial. JAMA Psychiatry. 2014;71(5):547–556. doi:10.1001/jamapsychiatry.2013.4546.
  • Witkiewitz K, Warner K, Sully B, et al. Randomized trial comparing mindfulness-based relapse prevention with relapse prevention for women offenders at a residential addiction treatment center. Subst Use Misuse. 2014;49(5):536–546. doi:10.3109/10826084.2013.856922.
  • Grant S, Colaiaco B, Motala A, et al. Mindfulness-based relapse prevention for substance use disorders: a systematic review and meta-analysis. J Addict Med. 2017;11(5):386–396. doi:10.1097/ADM.0000000000000338.
  • Parisi A, Roberts RL, Hanley AW, et al. Mindfulness-Oriented recovery enhancement for addictive behavior, psychiatric distress, and chronic pain: a multilevel meta-analysis of randomized controlled trials. Mindfulness (N Y). 2022;13(10):2396–2412. doi:10.1007/s12671-022-01964-x.
  • Kang D, Fairbairn CE, Ariss TA. A meta-analysis of the effect of substance use interventions on emotion outcomes. J Consult Clin Psychol. 2019;87(12):1106–1123. doi:10.1037/ccp0000450.
  • Roos C, Bowen S, Witkiewitz K. Approach coping and substance use outcomes following mindfulness-based relapse prevention among individuals with negative affect symptomatology. Mindfulness (N Y). 2020;11(10):2397–2410. doi:10.1007/s12671-020-01456-w.
  • Witkiewitz K, Bowen S. Depression, craving, and substance use following a randomized trial of mindfulness-based relapse prevention. J Consult Clin Psychol. 2010;78(3):362–374. doi:10.1037/a0019172.
  • Witkiewitz K, Bowen S, Douglas H, et al. Mindfulness-based relapse prevention for substance craving. Addict Behav. 2013;38(2):1563–1571. doi:10.1016/j.addbeh.2012.04.001.
  • Garland EL, Fix ST, Hudak JP, et al. Mindfulness-Oriented recovery enhancement remediates anhedonia in chronic opioid use by enhancing neurophysiological responses during savoring of natural rewards. Psychol Med. 2023;53(5):2085–2094. doi:10.1017/S0033291721003834.
  • Froeliger B, Mathew AR, McConnell PA, et al. Restructuring reward mechanisms in nicotine addiction: a pilot fMRI study of mindfulness-oriented recovery enhancement for cigarette smokers. Evid Based Complementary Alternative Med. 2017;2017:1–10. doi:10.1155/2017/7018014.
  • Priddy SE, Howard MO, Hanley AW, et al. Mindfulness meditation in the treatment of substance use disorders and preventing future relapse: neurocognitive mechanisms and clinical implications. Subst Abuse Rehabil. 2018;9:103–114. doi:10.2147/SAR.S145201.
  • Garland EL, Atchley RM, Hanley AW, et al. Mindfulness-Oriented recovery enhancement remediates hedonic dysregulation in opioid users: neural and affective evidence of target engagement. Sci Adv. 2019;5(10):eaax1569. doi:10.1126/sciadv.aax1569.
  • Garland EL, Froeliger B, Howard MO. Effects of mindfulness-Oriented recovery enhancement on reward responsiveness and opioid cue-reactivity. Psychopharmacology. 2014;231(16):3229–3238. doi:10.1007/s00213-014-3504-7.
  • Garland EL, Froeliger B, Howard MO. Neurophysiological evidence for remediation of reward processing deficits in chronic pain and opioid misuse following treatment with mindfulness-Oriented recovery enhancement: exploratory ERP findings from a pilot RCT. J Behav Med. 2015;38(2):327–336. doi:10.1007/s10865-014-9607-0.
  • Wilson AD, Roos CR, Robinson CS, et al. Mindfulness-based interventions for addictive behaviors: implementation issues on the road ahead. Psychol Addict Behav. 2017;31(8):888–896. doi:10.1037/adb0000319.
  • Bowen S, Chawla N, Marlatt GA. Mindfulness-based relapse prevention for addictive behaviors: a clinician’s guide. New York, NY: The Guilford Press; 2011.
  • Price M, Yuen EK, Goetter EM, et al. mHealth: a mechanism to deliver more accessible, more effective mental health care. Clin Psychol Psychother. 2014;21(5):427–436. doi:10.1002/cpp.1855.
  • Sheet MF. Internet and Technology. Pew research center. 2019.
  • Fairburn CG, Patel V. The impact of digital technology on psychological treatments and their dissemination. Behav Res Ther. 2017;88:19–25. doi:10.1016/j.brat.2016.08.012.
  • Marsch LA, Carroll KM, Kiluk BD. Technology-based interventions for the treatment and recovery management of substance use disorders: a JSAT special issue. J Subst Abuse Treat. 2014;46(1):1–4. doi:10.1016/j.jsat.2013.08.010.
  • Pratap A, Neto EC, Snyder P, et al. Indicators of retention in remote digital health studies: a cross-study evaluation of 100,000 participants. NPJ Digit Med. 2020;3(1):21. doi:10.1038/s41746-020-0224-8.
  • Carroll KM, Kiluk BD. Cognitive behavioral interventions for alcohol and drug use disorders: through the stage model and back again. Psychol Addict Behav. 2017;31(8):847–861. doi:10.1037/adb0000311.
  • Spijkerman M, Pots WTM, Bohlmeijer E. Effectiveness of online mindfulness-based interventions in improving mental health: a review and meta-analysis of randomised controlled trials. Clin Psychol Rev. 2016;45:102–114. doi:10.1016/j.cpr.2016.03.009.
  • Segal ZV, Dimidjian S, Beck A, et al. Outcomes of online mindfulness-based cognitive therapy for patients with residual depressive symptoms: a randomized clinical trial. JAMA Psychiatry. 2020;77(6):563–573. doi:10.1001/jamapsychiatry.2019.4693.
  • Bricker JB, Mull KE, McClure JB, et al. Improving quit rates of web-delivered interventions for smoking cessation: full-scale randomized trial of WebQuit. org versus smokefree. gov. Addiction. 2018;113(5):914–923. doi:10.1111/add.14127.
  • Bricker JB, Watson NL, Mull KE, et al. Efficacy of smartphone applications for smoking cessation: a randomized clinical trial. JAMA Intern Med. 2020;180(11):1472–1480. doi:10.1001/jamainternmed.2020.4055.
  • Skrzynski CJ, Karoly H, Ellingson J, et al. Comparing the efficacy of mindfulness-based relapse prevention versus relapse prevention for alcohol use disorder: a randomized control trial. J Stud Alcohol Drugs. 2023;84(4):560–569. jsad doi:10.15288/jsad.21-00392.
  • Bowen S, Chawla N, Collins SE, et al. Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial. Subst Abus. 2009;30(4):295–305. doi:10.1080/08897070903250084.
  • Linehan MM. DBT skills training manual. 2nd ed. New York, NY: Guilford Press; 2015.
  • Roos CR, Harp NR, Vafaie N, et al. Randomized trial of mindfulness-and reappraisal-based regulation of craving training among daily cigarette smokers. Psychol Addict Behav. 2023;37(7):829–840. doi:10.1037/adb0000940.
  • O’Daffer A, Colt SF, Wasil AR, et al. Efficacy and conflicts of interest in randomized controlled trials evaluating headspace and calm apps: systematic review. JMIR Ment Health. 2022;9(9):e40924. doi:10.2196/40924.
  • Witkiewitz K, Bowen S, Harrop EN, et al. Mindfulness-based treatment to prevent addictive behavior relapse: theoretical models and hypothesized mechanisms of change. Subst Use Misuse. 2014;49(5):513–524. doi:10.3109/10826084.2014.891845.
  • Carroll KM, Ball SA, Martino S, et al. Computer-assisted delivery of cognitive-behavioral therapy for addiction: a randomized trial of CBT4CBT. Am J Psychiatry. 2008;165(7):881–888. doi:10.1176/appi.ajp.2008.07111835.
  • Vilardaga R, Rizo J, Zeng E, et al. User-centered design of learn to quit, a smoking cessation smartphone app for people with serious mental illness. JMIR Serious Games. 2018;6(1):e8881. doi:10.2196/games.8881.
  • Onken LS, Carroll KM, Shoham V, et al. Re-envisioning clinical science: unifying the discipline to improve public health. Clin Psychol Sci. 2014;2(1):22–34. doi:10.1177/2167702613497932.
  • Powtoon. Powtoon.com. 2023.
  • Articulate. Articulate.com. 2021.
  • Qualtrics. Qualtrics.com. 2023.
  • Kallio H, Pietilä AM, Johnson M, et al. Systematic methodological review: developing a framework for a qualitative semi-structured interview guide. J Adv Nurs. 2016;72(12):2954–2965. doi:10.1111/jan.13031.
  • Brooke J. SUS: a retrospective. J Usability Stud. 2013;8(2):29–40.
  • Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res. 2017;17(1):88. doi:10.1186/s12913-017-2031-8.
  • Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 2006;3(2):77–101. doi:10.1191/1478088706qp063oa.
  • Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Supplement 20):22–33. quiz 34–57
  • Bickel WK, Marsch LA, Buchhalter AR, et al. Computerized behavior therapy for opioid-dependent outpatients: a randomized controlled trial. Exp Clin Psychopharmacol. 2008;16(2):132–143. doi:10.1037/1064-1297.16.2.132.